ATC Group: P01AX11 Nitazoxanide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of P01AX11 in the ATC hierarchy

Level Code Title
1 P Antiparasitic products, insecticides and repellents
2 P01 Antiprotozoals
3 P01A Agents against amoebiasis and other protozoal diseases
4 P01AX Other agents against amoebiasis and other protozoal diseases
5 P01AX11 Nitazoxanide

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 1 g

Active ingredients in P01AX11

Active Ingredient Description
Nitazoxanide

Related product monographs

Title Information Source Document Type  
ALINIA Tablet / Oral suspension FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Estonia (EE)

Mexico (MX)

Nigeria (NG)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.